Use of in Vitro Systems to Model in Vivo Degradation of Therapeutic Monoclonal Antibodies

doi 10.1021/acs.analchem.8b00183.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Monoclonal Antibodies: How to Use Them in Practice

Oncologist
Cancer ResearchMedicineOncology
1997English

Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Degradation Products in Atherosclerosis. Use of Monoclonal Antibodies

Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
1989English

Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by in Vitro and in Vivo Infection

PLoS ONE
Multidisciplinary
2015English

In Vitro and in Vivo Studies of Monoclonal Antibodies With Prominent Bactericidal Activity Against Burkholderia Pseudomallei and Burkholderia Mallei

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2011English

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect Against Ebolavirus Infection in a Mouse Model

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Degradation of 6-Methyl-2′-Deoxyuridine in the in Vivo and in Vitro Systems of Escherichia Coli

Nucleic Acids Research
Genetics
1974English

Current Use of Monoclonal Antibodies in the Treatment of Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Human Monoclonal Fab Antibodies Against West Nile Virus and Its Neutralizing Activity Analyzed in Vitro and in Vivo

Journal of Antivirals & Antiretrovirals
2009English

Isotype-Dependent Inhibition of Tumor Growth in Vivo by Monoclonal Antibodies to Death Receptor 4

Journal of Immunology
AllergyImmunology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy